Records containing: Prostate Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-04-24Phase I Study of the Pharmacokinetics and Pharmacodynamics of ZD6474 in Combination With Docetaxel in Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2017-04-24Does Androgen Suppression Treatment In Prostate Cancer Reduce Myocardial Blood Flow Reserve?
-
CLINICAL_TRIALS study record update · 2017-04-24Effect of Enzalutamide Dose Reduction on Fatigue, Cognition, and Drug Trough Levels in Patients With Prostate Cancer
-
CLINICAL_TRIALS study record update · 2017-04-20Cancer Prevention and Treatment Among African American Older Adults
-
CLINICAL_TRIALS study record update · 2017-04-20A Phase II Trial of a Combination Herbal Therapy for Men With Biochemical Recurrence of Prostate Cancer After Initial Local Therapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-04-19Focal Therapy Using High Intensity Focused Ultrasound (ABLATHERM®) for Localised Prostate Cancer
-
CLINICAL_TRIALS study record update · 2017-04-18[F-18]-Fluorodeoxyglucose (FDG) Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer
-
CLINICAL_TRIALS study record update · 2017-04-17Intermittent Androgen Deprivation in Patients With Stage D2 Prostate Cancer, Phase III
-
CLINICAL_TRIALS study record update · 2017-04-13A Phase 2, Randomized, Open-Label, Parallel Group Study Evaluating the Safety and Efficacy of TAK-385, an Oral Gonadotropin-Releasing Hormone (GnRH) Antagonist, for Patients With Localized Prostate Cancer Requiring Neoadjuvant and Adjuvant Androgen Deprivation Therapy With External Beam Radiation Therapy (EBRT)
-
CLINICAL_TRIALS study record update · 2017-04-13Analysis of Technique Comparison With a Vacuum Erection Device as Part of an Erectile Rehabilitation Program Following Robotic Radical Prostatectomy: A Randomized Comparison of Methodology
-
CLINICAL_TRIALS study record update · 2017-04-13A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
-
CLINICAL_TRIALS study record update · 2017-04-12A Phase II Trial of Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancer Previously Treated With Docetaxel
-
CLINICAL_TRIALS study record update · 2017-04-12An Open Label Study of Sipuleucel-T in Men With Metastatic Castrate Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2017-04-11Phase Ib/II Evaluation of RAD001 With Docetaxel and Bevacizumab in Patients With Metastatic Androgen Independent Prostate Cancer
-
CLINICAL_TRIALS study record update · 2017-04-10Pilot Study Investigating the Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer
-
CLINICAL_TRIALS study record update · 2017-04-07Phase II Study of BKM120 in Men With Metastatic Castration-Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2017-04-06Facilitating Participation in a Prostate Cancer Family Risk Assessment Program
-
CLINICAL_TRIALS study record update · 2017-04-04Multi-Centre, Multi-Indication, Two-Stage, Oncological Study to Retrospectively Assess and Prospectively Validate the Predictive Accuracy of PrediCare - a Standalone, Treatment Decision Support Software Device for Predicting Time-to-Progression in Individual Patients Under Standard of Care Treatments
-
CLINICAL_TRIALS study record update · 2017-03-31A Phase II Study of ABT-263/Abiraterone (Arm A) or ABT-263/Abiraterone and Hydroxychloroquine (Arm B) in Patients With Metastatic Castrate Refractory Prostate Cancer (CRPC) and Progression Following Chemotherapy and Abiraterone
-
CLINICAL_TRIALS study record update · 2017-03-29Leuprorelin Acetate SR 11.25 mg Injection Kit Specified Drug-use Survey "Long-term Use Survey in Prostate Cancer Patients (96 Weeks)"
-
CLINICAL_TRIALS study record update · 2017-03-29Safety and Pharmacokinetics of ODM-201 in Patients With Castrate Resistant Prostate Cancer: Open, Non-randomised, Uncontrolled, Multicentre, Multiple Dose Escalation Study With a Randomised Phase II Expansion Component
-
CLINICAL_TRIALS study record update · 2017-03-29Phase II Study of Neoadjuvant IMC-A12 Combined With Androgen Deprivation Prior to Prostatectomy
-
CLINICAL_TRIALS study record update · 2017-03-28Randomized, Open-Label, 1-Way Parallel, Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex (Reference) Following a 50 mg Dose in Healthy Subjects Under Fed Conditions.
-
CLINICAL_TRIALS study record update · 2017-03-28Randomized, Open-Label, 1-Way Parallel, Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex (Reference) Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions.
-
CLINICAL_TRIALS study record update · 2017-03-24An Open Label Biomarker Driven Phase II Clinical Trial of Abiraterone Acetate (AA) Re-Challenge in Patients With Metastatic Castration-Resistant Prostate Cancer and Prior Response to AA